Background: Growing evidence suggests that dairy products may have beneficial cardiometabolic effects. The current
Introduction
Noncommunicable diseases are the main cause of morbidity, disability, and health care costs, accounting for nearly two-thirds of deaths worldwide. Cardiovascular disease is the leading cause of death in the United States and globally (1, 2) .
Metabolic syndrome (MetSyn) 9 is a clustering of interrelated risk factors for cardiovascular disease (CVD) and type 2 diabetes mellitus, which occur together more often than by chance alone, including high blood pressure, low fasting HDL cholesterol, high fasting TGs, high fasting blood glucose, and abdominal obesity (3) . The consumption of dairy products and associated nutrients has been suggested to improve MetSyn characteristics (4, 5) .
Evidence that supports a beneficial effect of dairy products on CVD risk factors came initially from the Dietary Approaches to Stop Hypertension trial (6) . A meta-analysis of randomized studies found small effects of moderate increases in dairy products on cardiometabolic risk factors (7) . A main limitation is that no trials, to our knowledge, have directly compared the effect of lowand full-fat dairy intake on cardiometabolic risk (7) . Dairy products are complex and generally dense in nutrients, and the effects of their saturated fat content on MetSyn needs to be elucidated (6, 8) .
Our recent findings from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) study suggested that the intake of total dairy products, especially from fermented products, was inversely associated with measures of glycemia and insulinemia, and the SFA myristic acid may have mediated this association (9) . Data from 2 other large cohort studies suggested that circulating biomarkers of dairy fat were not significantly associated with stroke and that SFAs, especially those that originate from dairy, do not increase CVD risk (5, 10) . Considering the high prevalence of dairy consumption, even in low-and middleincome countries (11) , and the recommendation to limit fullfat dairy intake (12) , more studies are needed to evaluate the association of dairy intake and its components with cardiovascular risk. This study sought to investigate the association between dairy consumption, types of dairy products, including fat content, and MetSyn at the baseline of a large multicentric cohort study.
Methods

Study design
ELSA-Brasil is a multicenter cohort study designed to address the incidence of CVDs and diabetes and major associated risk factors. A total of 15,105 civil servants from selected universities and research institutions between the ages of 35 and 74 y living in 6 cities (Salvador, Belo Horizonte, Rio de Janeiro, Sao Paulo, Vitoria, and Porto Alegre) were assessed between August 2008 and December 2010. All participants gave written consent to participate, and the research protocol was approved by the local ethics committee of each institution involved.
Study participants
The exclusion criteria were known diabetes (diabetes status reported during initial interviews), taking oral hypoglycemic medications or insulin (n = 1473), CVD (n = 1280), cancer (n = 695), and other chronic diseases (n = 2649). We also excluded both a fasting state below 12 h and above 15 h (n = 542) and participants with a reported energy intake of #1298 kcal/d (second percentile) or high $6372 kcal/d (98th percentile) (n = 629). Some participants had more than 1 exclusion criteria. Our final sample comprised 9835 participants.
Data collection and key measurements
Dairy intake and other diet variables. A validated FFQ with 114 items was administered to evaluate the participantsÕ usual intake over the past 12 mo (13). For each food item ascertained, the ELSA-Brazil FFQ included measures of portions and frequency of consumption, the latter of which had 8 response options: >3 times/d, 2-3 times/d, 1 time/d, 5-6 times/wk, 2-4 times/wk, 1 time/wk, 1-3 times/mo, and never/almost never.
The following items were included as dairy products: milk (skimmed milk, low-fat milk, whole milk), yogurt (regular, low-fat), cheese (regular, low-fat), cheese spread, cream cheese base (regular, low-fat), ice cream, desserts made with milk (pudding, mousses), and butter. Mixed dishes and products for which the contribution of dairy products was deemed negligible were not included in the derivation of our dairy intake estimates. Total dairy intake was calculated as the sum of all dairy products reported in the dietary questionnaire. We computed servings per day for total dairy intake and the following dairy subgroups: full-and low-fat dairy, milk, cheese, yogurt, cheese spread and cream cheese base, dairy-based desserts, butter, and fermented dairy. The amount of grams per serving for each dairy food was 240 g for milk, 120 g for yogurt, 30 g for cheese and cream cheese, 80 g for ice cream, 50 g for dairy dessert (pudding and mousse), and 5 g for butter.
The nondairy food groups were computed in the analysis by grams per day. As covariates, we assessed the consumption of fruits, vegetables, whole and refined grains, nondairy sweets and desserts, processed and unprocessed red and white meats, eggs, beans, coffee, tea, juice, and sodas.
We used the University of Minnesota Nutrition Data System for Research database (14) to determine the nutritional composition of the food items from the FFQ based on the following equation:
size of serving ðin standard portionsÞ 3 frequency of consumption 3 weight ðof a standard portion in gramsÞ 3 nutritional composition of the food serving ðgrams of nutrient per total grams of food itemÞ ð1Þ
In this equation, the values used for the frequency categories were as follows: 3 for >3 times/d, 2.5 for 2-3 times/d, 1 for once per day, 0.8 for 5-6 times/wk, 0.4 for 2-4 times/wk, 0.1 for once per week, 0.07 for 1-3 times/mo, and 0 for never/almost never.
The Anthropometrics. Anthropometric measures (weight, height, and waist circumference) were obtained from participants while they were standing, dressed in a light uniform standardized for the study, and without shoes after an 8-15-h fast. We measured body weight to the nearest 0.1 kg with a calibrated Toledo 2096PP balance (Toledo do Brasil Ltda, Brazil) and height with a vertical Seca-SE-216 stadiometer (Seca Brasil, Brazil) to the nearest 0.1 cm. Waist circumference was measured with a tape measure to the nearest 0.1 cm around the midpoint between the inferior border of the ribs and the iliac crest. BMI was calculated as weight in kilograms divided by height in square meters. A BMI $30 kg/m 2 was considered obese.
Blood pressure. Resting blood pressure was measured 3 times at 1-min intervals while participants remained in the seated position after a 5-min rest and obtained using a 765CP oscillometric sphygmomanometer (Omron). The average of the second and third measurements was used in the analyses. Hypertension was defined as systolic blood pressure $140 mm Hg or diastolic blood pressure $90 mm Hg or verified treatment with antihypertensive medication during the past 2 wk.
Subclinical measures. Participants arrived at the clinic after an overnight fast of 8 to 15 h and were instructed to avoid heavy physical activity during the previous day. Blood was drawn by venipuncture, and a standard 2-h 75-g oral glucose tolerance test was administered for all participants who did not report a diagnosis or previous treatment for diabetes. Glucose was measured by an ADVIA 1200 chemistry hexokinase system (Siemens). Glycated hemoglobin was measured using an HPLC assay (Bio-Rad D-10 Dual Program Laboratories), which is certified by the National Glycohemoglobin Standardization Program. We calculated the insulin sensitivity index composite with the formula 10; 000=Of½fasting glucoseðmg=dLÞ3fasting insulinðmU=mLÞ3 ½mean glucose3mean insuling and used fasting and 2-h values for the means (15) .
HDL cholesterol and TGs were estimated using enzymatic procedures (ADVIA 1200). Low HDL cholesterol was defined by sex: men <1.03 mmol/L (40 mg/dL) and women <1.29 mmol/L (50 mg/dL). Hypertriglyceridemia was considered when $1.69 mmol/L (150 mg/dL).
Metabolic syndrome definition. For diagnosing MetSyn, we used the joint interim statement consensus criteria (3), which require the presence of any 3 of the following 5 risk factors: elevated waist circumference ($102 cm in men and $88 cm in women), elevated TGs or drug treatment ($150 mg/dL), reduced HDL cholesterol or drug treatment (<40 mg/dL for men and <50 mg/dL for women), elevated blood pressure or drug treatment ($130 mm Hg and/or diastolic blood pressure $85 mm Hg), and elevated fasting glucose ($100 mg/dL), which included those classified as having diabetes as ascertained simply by laboratory measures at baseline.
In addition, a metabolic risk score (MetScore) was computed using an approach similar to that previously reported (16) as the mean of z scores of the continuous metabolic risk factors (waist circumference, systolic blood pressure, HDL cholesterol (negative z score), TGs, and fasting glucose as follows:
HDL cholesterol and TGs were log-transformed to achieve normality before computing z scores. The z scores for waist circumference and HDL cholesterol were sex-specific. We also computed a second MetScore using log-transformed values of 2 h of postload glucose instead of fasting glucose.
Covariates: demographics, socioeconomics, and behaviors. Interviews and examinations were conducted by trained health professionals with strict quality control. Standardized questionnaires provided information on demographics (age, sex, race, educational level, family income, occupation status, study center), family history of diabetes, smoking (current and previous), and menopausal status. Alcohol intake was estimated as the sum of ethanol (g/wk) of all beverages consumed. Leisure-time physical activity was defined using the long form of the International Physical Activity Questionnaire according to its guidelines for data processing and analysis. Median values and interquartile ranges were computed for walking, moderate intensity activities, vigorousintensity activities, and a combined total leisure-time physical activity score (17) . All continuous scores were expressed in metabolic equivalent minutes per week.
Statistical analysis
Multivariable linear regression analysis was performed to test the association of servings per day of dairy products with the MetSyn components: waist circumference, TGs, HDL cholesterol, systolic blood pressure, and fasting glucose. We adjusted for covariates (potential confounders) in 2 models, the first of which, model 1, included demographic covariates, menopausal status, and family history of diabetes; model 2 included all variables from model 1 plus nondietary (smoking status, physical activity) and dietary factors (alcohol intake, energy intake, and nondairy food groups). For the nondairy food groups, we retained in the models those with a P value <0.20. This approach, while decreasing the number of covariates in any given model, resulted in slightly different sets of covariates in models that evaluated different outcomes. We used the same modeling approach to evaluate total dairy and dairy subgroups associations with MetScore. Multiple logistic regression was used to evaluate the association between dairy consumption and MetSyn when expressed categorically, and we included in model 1 demographics, menopausal status, family history of diabetes, and behaviors; for model 2 we added nondairy food groups. A linear trend was tested by modeling categorical dairy servings per day (<1, 1-2, >2-4, and >4) as a continuous variable in the multivariable regression models. We evaluated the potential mediation of the dairy associations by adding dairy nutrient components to the final models. A correlation matrix was used to explore multicollinearity, and variance inflation factor values >10 indicated multicollinearity. All analyses were performed with the statistical package SPSS version 18 (IBM), and 5% was considered significant.
Results
The mean 6 SD age at baseline was 50.7 6 8.7 y, and 54.8% (n = 5390) were women. On average, participants consumed 344 g/d total dairy products, and the intake of full-fat products was higher than low-fat consumption, corresponding to 189 and 155 g/d, respectively. Mean dairy food subgroup intakes were 241 g/d for milk, 38 g/d for cheese, 37.8 g/d for yogurt, 5.2 g/d for cream cheese, 1.6 g/d for butter, 12 g/d for ice cream, and 8 g/d for dairy desserts. Table 1 presents baseline characteristics for the overall sample and is stratified by categories of dairy consumption. Dairy intake was higher in whites than in other ethnic groups and in participants with a university degree than in those with less formal education. Higher dairy consumption was also observed among nonsmokers and those who drank less alcohol, did more moderate and vigorous physical activity, and ate fruits and vegetables every day. Values of proteins, total fat, and saturated fat intake, when expressed as a percentage of energy intake, increased according to higher dairy product consumption.
Means and frequencies of cardiometabolic risk factors for the overall sample and by dairy servings per day are also presented in Table 1 . Plasma glucose and blood pressure values declined with a greater consumption of dairy products. Thus, there were less cases of diabetes (as ascertained solely by study-determined laboratory values) and hypertension in participants with higher dairy consumption. Although TG concentrations were lower in participants with high dairy consumption, those of HDL cholesterol were higher only in women who consumed more dairy products. MetScore was inversely related to categories of dairy intake.
An examination of the cardiometabolic risk factors as categorical variables revealed that the frequency of elevated waist circumference was 32.2% in the overall sample. Participants who had elevated TGs or who were taking fibrates or nicotinic acid represented 29.9% of the sample, and those with low HDL cholesterol or taking those medications represented 17.2%. Those with blood pressure $130 mm Hg for systolic and/or $85 mm Hg for diastolic or medication for hypertension within the last 2 wk made up 38.9%. Those with fasting glucose >100 mg/dL or using antidiabetic medication corresponded to 68.6% of participants. Table 2 presents adjusted means of cardiometabolic risk factors across levels of total dairy intake. Significant inverse doseresponse associations were found between total dairy intake and adjusted mean values of systolic and diastolic blood pressure, 2-h postload glucose, and TGs. We found a positive graded association between total dairy intake and HDL cholesterol levels in women only. We did not find a significant linear trend between total dairy consumption and fasting glucose in model 2 after full adjustment. Visual inspection of the trends across the categories presented in Table 2 showed no important nonlinearity in the relevant range of dairy servings per day, a finding corroborated by no or minimal significance for quadratic in terms of servings per day when added in additional models (data not shown). Table 3 summarizes the adjusted means of the MetScore by total dairy intake categories and across subgroups of dairy (fulland low-fat) intake. We observed a graded inverse association between total and full-fat dairy with MetScore, but we did not find the same association for low-fat dairy products in models adjusted for demographics, behavioral risk factors, caloric intake, and nondairy food groups. In a fully adjusted model fit with both full-and low-fat dairy intake, thus each being adjusted for the other, we found similar bs 6 SEs and P values (20.070 6 0.02, P = 0.001 for a 1 serving per day difference in full fat and 20.022 6 0.02, P = 0.280 for a 1 serving per day difference in low-fat dairy intake). When we computed the MetScore in similarly adjusted additional analyses using log-transformed 2-h postload glucose instead of fasting glucose, the graded inverse association between total dairy with MetScore became stronger (20.132 6 0.04, P = 0.001), and we found a similar association between full-fat dairy and MetScore (20.123 6 0.03, P < 0.001). The findings were consistent across categories of sex and race in a stratified analysis. Despite a strong association between continuous MetScore and dairy products, when using the current MetSyn criteria of the joint interim statement consensus (3), we found statistically significant associations only in the model adjusted by demographics, caloric intake, smoking, alcohol, and physical activity (consumption of >4 dairy servings per day represented a 27% lower odds of MetSyn; 95% CI: 0.62, 0.87). In the fully adjusted model, we did not observe a statistically significant association (OR: 0.90; 95% CI: 0.75, 1.08). However, when we analyzed the relation between total dairy intake and a high MetScore (above the 75th percentile), participants with a reported intake of >4 dairy servings per day had 25% lower odds (OR: 0.75; 95% CI: 0.61, 0.92) of MetSyn in the fully adjusted model ( Table 4) .
We observed a strong inverse association between full-fat dairy and MetScore (difference of 20.062 6 0.02 servings per day, P = 0.002) when analyzing subgroups of dairy consumption. This association was also present for butter, yogurt, and fermented dairy. For dairy-based desserts, we found a positive association with MetScore (0.169 6 0.07, P = 0.023) ( Table 5) . Several nutrients were evaluated as possible mediators of dairy consumption and MetScore. These nutrients included animal protein, total FAs, and SFAs from dairy products (including specific SFAs) and butyric, caproic, caprylic, capric, lauric, myristic, palmitic, stearic, palmitoleic/monounsaturated, and polyunsaturated acids when expressed as a percentage of energy intake. We also considered as possible mediators cholesterol, lactose, sucrose, vitamins A and D, calcium, phosphorus, magnesium, sodium, and potassium. After adjusting additionally for saturated fat from dairy products ( Table 6) , associations of total dairy (20.023 6 0.03, P = 0.37) and full-fat dairy (20.025 6 0.02, P = 0.33) intake with MetScore were no longer , physical activity (metabolic equivalent min/wk), and BMI (except for the waist model)] (nondairy food groups included in the models varied across outcomes because only variables with P , 0.20 in the final model were maintained); systolic blood pressure: fruits, vegetables, whole grains, coffee, sodas, and processed red meat; diastolic blood pressure: fruits, whole grains, coffee, sodas, processed red meat, non-dairy sweets and desserts; fasting glucose: fruits, vegetables, refined grains, coffee, sodas, processed red meat, eggs, and nondairy sweets and desserts; 2-h postload glucose: fruits, whole grains, coffee, eggs, and nondairy desserts; TGs: fruits, vegetables, refined grains, coffee, tea, sodas, and nondairy sweets and desserts; HDL cholesterol (men): fruits, refined grains, sodas, and juice; HDL cholesterol (women): fruits, refined grains, coffee, tea, sodas, juice, unprocessed red meat, and beans; waist (men): fruits, vegetables, whole grains, sodas, juice, unprocessed red meat, processed red and white meat, beans, eggs, and nondairy sweets and desserts; and waist (women): vegetables, refined grains, coffee, tea, sodas, unprocessed red and white meat, processed red and white meat, eggs, and nondairy sweets and desserts. 3 Values are b 6 SE. 4 Linear trend was tested by modeling dairy servings per day (,1, 1-2, .2-4, and .4 sv/d) as a continuous variable in the multivariable regression models.
present. In each of these models, greater SFA intake from dairy products was associated with a lower MetScore (P < 0.001). These findings suggest potential mediation through SFAs consumed in dairy products. No other potential mediators were found.
Discussion
After adjusting for demographics, menopausal status, family history of diabetes, dietary intake, nondietary lifestyle factors, and BMI in this large cohort study of Brazilian adults, we observed a strong inverse association between total dairy intake and cardiometabolic risk with a linear dose-response pattern. Interestingly, this association was observed for full-fat dairy products, butter, and yogurt but not for low-fat dairy products.
Men and women who consumed >4 servings of dairy products per day had lower levels of systolic and diastolic blood pressure, 2-h postload glucose, and TGs. There was a positive monotonic trend between the intake of dairy products and adjusted mean HDL cholesterol in women only. We also found evidence that SFAs from dairy products may mediate these associations. Our results are consistent with previous prospective and cross-sectional research (4, (18) (19) (20) (21) . The protective effect of dairy intake in relation to MetSyn has been reported previously in multicenter prospective cohort studies. In the Atherosclerosis Risk in Communities study, a cohort of 9514 participants from 4 US communities, individuals in the highest quintile of dairy consumption had a 13% (CI 95%: 0.77, 0.98) lower risk of developing MetSyn, and this finding was consistent across sex and BMI categories (22) . In the Coronary Artery Risk Development in Young Adults study that followed ;3,000 participants, the highest category of dairy consumption ($5/d) compared with the lowest was associated with a 70% reduction (95% CI: 0.14, 0.70) in a 10-y cumulative incidence of the insulin resistance syndrome (defined differently than MetSyn) in over-but not normal-weight participants (23) . In the MultiEthnic Study of Atherosclerosis, 316 incident CVD cases were observed in 5209 participants between the ages of 45 and 84 y. Each 5-unit increment in the percentage of energy from dairy fat was associated with a 38% lower risk of CVD (95% CI: 0.47, 0.82) (24) . The Epidemiological Study on the Insulin Resistance Syndrome, a French cohort, also found inverse associations between dairy products and MetSyn and diabetes risk (25) . Similar to our study, the Epidemiological Study on the Insulin Resistance Syndrome also found no association between cheese intake and MetSyn or diabetes. By contrast, some studies have suggested positive or null associations between the intake of dairy products and MetSyn or CVD risk (26) (27) (28) . Because of the somewhat inconsistent evidence, metaanalyses can be helpful. The relative risk of MetSyn when combining results of the 4 observational studies in subjects with high milk or dairy consumption was 0.74 (95% CI: 0.64, 0.84) relative to the risk in those with low consumption (29) . Data from a dose-response meta-analysis that included 13,518 participants and 2283 CVD (fatal and nonfatal) cases were analyzed in 4 other prospective cohort studies, with milk as the main exposure. An inverse association was found between milk intake and risk of overall CVD (RR = 0.94 per 200 mL/d; 95% CI: 0.89, 0.99 per 200 mL/d) (30) . A different meta-analysis of observational studies evaluated the association between high-fat dairy products and obesity, cardiovascular disease, and MetSyn and found high-fat dairy intake to be inversely associated with the outcomes in 11 of 16 studies (31). However, a meta-analysis of 20 mostly short-term randomized controlled studies with 1677 healthy adults found no significant effects of increased dairy food on the cardiometabolic risk factors evaluated herein. The authors cautioned that most of the trials were small and of modest quality (7) .
We found a graded inverse association between total and full-fat dairy consumption and MetSyn in this study but no association for low-fat dairy consumption after fully adjusting for covariates. When we added dairy-related nutrients to the fully adjusted model, the results suggested that SFAs found in dairy products may be mediating the inverse association between dairy intake and MetSyn. The literature on SFAs and cardiovascular disease risk has been inconsistent and controversial (32) (33) (34) . Our results that suggest that it may in fact be the dairy fat content that explains the potential protective effect of dairy intake highlight an important issue in this area of research.
In our previous analysis of this same population, ELSABrasil, we found inverse associations between dairy consumption and levels of glycemia and insulinemia that were independent of obesity. This association was possibly mediated by myristic acid (9) . Myristic acid has been associated with increased LDL cholesterol and cardiovascular risk in epidemiological studies (35) (36) (37) . However, the role of myristic acid in raising plasma lipids and its impact on health outcomes are still controversial. Myristic and palmitic acids (both present in dairy products) increase LDL cholesterol, but myristic acid also increases HDL cholesterol (38) . In an experimental study, moderate quantities of myristic acid (1.2% and 1.8% of total energy) were found to be associated with decreases in total cholesterol, LDL cholesterol, TGs, and the ratio of total to HDL cholesterol (39) . In another study of healthy young subjects, myristic acid, present in dairy products, was chosen as a marker for the intake of milk fat and was inversely related to the LDL cholesterol level (40) .
Dairy products are dense in nutrients, and the impact of dietary SFAs on cardiovascular risk may be influenced by the food and nutrient matrix involved with dairy intake. The effects of other components of dairy intake should also be considered. For example, milk proteins have an angiotensin-converting enzyme-inhibitory effect (41) . The inhibition of the renin angiotensin system in adipocytes can potentially reduce obesity and hypertension. As a rich source of calcium, dairy products have been reported to reduce blood pressure and to be inversely associated with adiposity (18) . In our analyses, however, the only nutrient that materially changed the associations of dairy intake with the MetSyn was SFAs from dairy products. Because of collinearity and limited ranges of intakes for some FAs, we could not reach any clear conclusions on specific SFAs. Considering that this mediation analysis is exploratory in nature, we cannot draw definitive conclusions. This study has some limitations. We measured dairy intake and nutrients based on what participants reported in the FFQ, a typical choice in large epidemiologic studies, but this method is subject to random and systematic errors. We used cross-sectional data to identify the association of dairy consumption with the MetSyn, and because of the observational nature of our study, it is possible that our findings resulted from residual confounding despite the fact that we extensively adjusted for other dietary variables and risk factors. Strengths of this study include the direct measurements of the cardiometabolic risk factors and exclusion of subjects with known CVD, diabetes, stroke, or other chronic diseases.
The findings of this study, in which we adjusted for demographics, menopausal status, family history of diabetes, dietary intake, nondietary lifestyle factors, and BMI, suggest that greater dairy intake, especially of full-fat dairy products, may decrease the risk of MetSyn in middle-aged and older adults. Typical dietary guidelines, including the 2015 US guidelines now under review and the new Brazilian dietary guidelines published in 2014, recommend consuming low-fat instead of full-fat dairy products because of the concern that dairy fat could increase the risk for obesity and dyslipidemia (7, 12, 42) . However, our findings and the literature on the association of dairy products with obesity, cardiovascular disease, and diabetes do not support dietary guidelines that recommend only a low-fat dairy intake.
